Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Afton launches new Titanium hormone pellet insertion trocars

Afton Medical, a manufacturer of surgical instruments, has launched a new line of Titanium hormone pellet insertion trocars, designed for use with hormone replacement therapy.

The Titanium trocars, which are available in two sizes to accommodate 4.5mm-150mg-200mg and 3.0mm, 6 mg-125mg pellets, are designed specifically for hormone pellet therapy of Menopause, Perimenopause and Andropause (male menopause) patients.

The disposable and reusable stainless steel trocars are placed under the skin which dissolve slowly over time to release small physiologic doses of bioidentical hormones for approximately three to six months in women and up to nine months in men.

The studies demonstrated that when compared to conventional hormone replacement therapy, pellets offer relief of menopausal symptoms, maintenance of bone density, restoration of sleep patterns, and improvement in sex drive, libido, sexual response and performance.

In addition, patients who have had no success with other types of hormone therapy have a very high success rate with pellets.